Summit Investment Advisors »

Phathom Pharmaceuticals shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $56k 3.1k 18.08
2024-06-30 $32k 3.1k 10.30
2024-03-31 $33k 3.1k 10.62
2023-12-31 $28k 3.1k 9.13
2023-09-30 $32k 3.1k 10.37
2023-06-30 $23k 1.6k 14.32
2023-03-31 $11k 1.6k 7.14
2022-12-31 $14k 1.6k 8.74
2022-09-30 $17k 1.6k 10.71
2022-06-30 $13k 1.6k 8.19
2022-03-31 $22k 1.6k 13.85
2021-12-31 $31k 1.6k 19.52
2021-09-30 $51k 1.6k 32.12
2021-06-30 $54k 1.6k 34.01
2021-03-31 $35k 925 37.84
2020-12-31 $31k 925 33.51
2020-09-30 $34k 925 36.76
2020-06-30 $30k 925 32.43
2020-03-31 $24k 925 25.95
2019-12-31 $29k 925 31.35